Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation | Zendy

Benjamin A. Steinberg | Zendy; Sunghee Kim | Zendy; Jonathan P. Piccini | Zendy; Gregg C. Fonarow | Zendy; Renato D. Lópes | Zendy; Laine Thomas | Zendy; Michael D. Ezekowitz | Zendy; Jack Ansell | Zendy; Peter R. Kowey | Zendy; Daniel E. Singer | Zendy; Bernard J. Gersh | Zendy; Kenneth W. Mahaffey | Zendy; Elaine M. Hylek | Zendy; Alan S. Go | Zendy; Paul Chang | Zendy; Eric D. Peterson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation

Author(s) -

Benjamin A. Steinberg,

Sunghee Kim,

Jonathan P. Piccini,

Gregg C. Fonarow,

Renato D. Lópes,

Laine Thomas,

Michael D. Ezekowitz,

Jack Ansell,

Peter R. Kowey,

Daniel E. Singer,

Bernard J. Gersh,

Kenneth W. Mahaffey,

Elaine M. Hylek,

Alan S. Go,

Paul Chang,

Eric D. Peterson

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.002927

Subject(s) - medicine , atrial fibrillation , concomitant , hazard ratio , confidence interval , aspirin , population , odds ratio , cardiology , environmental health

The role of concomitant aspirin (ASA) therapy in patients with atrial fibrillation (AF) receiving oral anticoagulation (OAC) is unclear. We assessed concomitant ASA use and its association with clinical outcomes among AF patients treated with OAC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research